Hepatitis B can lead to liver disease. But we can prevent and manage this viral infection. Here’s what we know about the ...

Scientists discovered a way to block hepatitis B infection using an anticancer drug, offering hope for new treatments.

Chronic hepatitis B virus (HBV) infection continues to pose a major global health threat. The virus evades immune responses and antiviral therapies due to the persistence of covalently closed circular ...

Hepatitis B virus infection remains one of the leading causes of liver disease, including cirrhosis and hepatocellular carcinoma.

At least one-third of the world's population has been infected with the hepatitis B virus (HBV), and 400 million people are chronic carriers. In most populations, chronic HBV infection is the ...

Chronic hepatitis B (CHB) remains a major global health challenge, with functional cure achieved in only a small subset of patients. Current oral antiviral agents effectively suppress viral ...

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...

Adma Biologics (ADMA) shares soared 10.2% in the last trading session to close at $20.61. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

Australia's New South Wales Health has issued a warning after it was revealed that more than 200 mothers may have been ...

India has reported over 2,700 deaths due to Hepatitis B in the last five years. In 2024, as many as 607 deaths were reported. The highest number of deaths (124) were from Maharashtra, the Rajya Sabha ...

The US joins Moldova, Hong Kong, and New Zealand as countries to greenlight the company's Phase I trial of PBGENE-HBV.